Lung cancer costs UK £2.4bn a year

7 November 2012

The cost of lung cancer to the UK economy is £2.4 billion a year, according to a new research.

Oxford University noted that this type of cancer, which is the second most common in the UK (after breast cancer) and costliest, needs to be tackled in a far more comprehensive way.

The cost of cancer is worked out from the economic loss of premature loss of life and the time people take off from work because of illness or treatment.

Dr Jose Leal, author of the research, commented that the death rate from the disease remains high at 56 deaths per 100,000 people in the UK every year.

"Our research shows that cancers impact the economy as a whole - and not just the health service," the medical expert added.

"Premature deaths, time off work and unpaid care by friends and family account for 64 per cent of all cancer costs (£10.2bn) in the UK in 2009. These wider costs should be taken into account when deciding research priorities."

Dr Leal concluded by saying that cancers with the highest economic costs could offer the "highest expected returns from investment in research".

Posted by Jeanette Royston

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)